Industry News
OcuCell Receives Funding from the Georgia Eye Bank

OcuCell, a provider of ocular cell therapy, has announced funding from the Georgia Eye Bank. Establi...

read more
OcuCell Receives Funding from the Georgia Eye Bank
September 26, 2023
Apellis Receives Permanent J-Code for SYFOVRE®

The U.S. Centers for Medicare & Medicaid Services (CMS) have officially designated a specific J-code...

read more
Apellis Receives Permanent J-Code for SYFOVRE®
September 26, 2023
Orbis Partners with Alcon Foundation and Omega to Improve Eye Care in Zambia

Orbis International is launching a surgical training program in Zambia aboard the Orbis Flying Eye H...

read more
Orbis Partners with Alcon Foundation and Omega to Improve Eye Care in Zambia
September 25, 2023
BVI Acquires Medical Mix, Expanding its Footprint in Portugal and Spain

BVI announced its acquisition of Medical Mix, a specialized company in medical devices for ophthalmi...

read more
BVI Acquires Medical Mix, Expanding its Footprint in Portugal and Spain
September 25, 2023
Iveric Bio Partners with Eric Stonestreet to Raise Awareness of GA

Iveric Bio, an Astellas Company, has joined forces with Eric Stonestreet, a two-time Emmy® award-win...

read more
Iveric Bio Partners with Eric Stonestreet to Raise Awareness of GA
September 22, 2023
Ocugen's OCU400 Gene Therapy Shows Promising Results in Phase 1/2 Trial for RP and LCA

Ocugen has provided an update on its clinical study involving participants with retinitis pigmentosa...

read more
Ocugen's OCU400 Gene Therapy Shows Promising Results in Phase 1/2 Trial for RP and LCA
September 22, 2023
VSY Biotechnology Announces 2023 Ophthalmology Star Awards Winners

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, announced the winners...

read more
VSY Biotechnology Announces 2023 Ophthalmology Star Awards Winners
September 21, 2023
Neurophth’s Candidate Drug for ADOA Receives Australian Approval

Neurophth Therapeutics announced that the Australian Therapeutic Goods Administration (TGA) has gran...

read more
Neurophth’s Candidate Drug for ADOA Receives Australian Approval
September 19, 2023
SparingVision Reports Positive Initial Data for Retinitis Pigmentosa Gene Therapy Trial

SparingVision announced positive initial safety data from the Phase I/II clinical trial (referred to...

read more
SparingVision Reports Positive Initial Data for Retinitis Pigmentosa Gene Therapy Trial
September 18, 2023
NovaBay Pharmaceuticals Launches Avenova Allograft in the U.S.

NovaBay Pharmaceuticals announced the official launch of the Avenova Allograft in the United States ...

read more
NovaBay Pharmaceuticals Launches Avenova Allograft in the U.S.
September 15, 2023
More